Table 2 Correlation between VEGF-C and VEGFR-3 mRNA expression and clinicopathological factor
Clinicopathological factors | No. of patients | VEGF-C | P -value | VEGFR-3 | P -value |
|---|---|---|---|---|---|
Age | |||||
70> | 40 | 50.8±58.3 | 0.15 | 70.8±128.2 | 0.07 |
70⩽ | 34 | 33.6±41.5 | 31.3±38.0 | ||
Gender | |||||
Male | 54 | 41.2±49.1 | 0.64 | 35.4±53.4 | 0.1 |
Female | 20 | 47.5±59.3 | 99.3±163.3 | ||
T | |||||
1 | 28 | 51.7±62.3 | 0.17 | 85.9±148.9 | 0.09 |
2 | 32 | 32.5±44.8 | 34.4±43.7 | ||
N | |||||
(−) | 48 | 50.6±57.0 | 0.08 | 71.7±118.2 | 0.003 |
(+) | 26 | 28.7±37.0 | 17.5±21.6 | ||
Stage | |||||
I, II | 51 | 48.3±57.5 | 0.11 | 66.1±116.1 | 0.08 |
III, IV | 23 | 31.0±33.6 | 22.9±25.0 | ||
Histological type | |||||
Adenocarcinoma | 39 | 56.6±60.4 | 0.006 | 81.3±126.8 | 0.003 |
Squamous cell ca | 32 | 24.5±33.1 | 15.3±24.4 | ||
Differentiation | |||||
Adenocarcinoma | |||||
Well | 16 | 53.0±55.3 | 0.76 | 120.2±177.3 | 0.11 |
Mod or Poor | 23 | 59.1±64.8 | 35.9±54.1 | ||
Squamous cell ca | |||||
Well | 6 | 26.4±38.7 | 0.88 | 18.3±19.5 | 0.75 |
Mod or Poor | 26 | 24.0±32.6 | 14.7±25.7 | ||
